About Syenza News
Syenza News is a specialized media platform focused on providing news, analysis, and insights in the field of healthcare innovation, health economics, health technology assessment (HTA), pharmaceutical & medtech policy, and value science. Our primary audience includes healthcare professionals, policymakers, and industry stakeholders who rely on up-to-date, evidence-based information to make informed decisions and drive improvements in patient care and health system performance.
Syenza News is recognized for its strategic insights into healthcare policy, technology, and economics, aiming to bridge the gap between research, innovation, and real-world healthcare delivery.
Key characteristics of Syenza News:
- Content Focus: We cover advances in health technology (including AI and digital health), clinical practice, healthcare policy, health economics, and global health trends.
- Mission: We empower healthcare professionals by delivering high-impact perspectives on value science and supporting strategic decision-making in the healthcare sector.
- Format: We publish news articles, expert commentary, and analysis on current developments in healthcare, often highlighting innovations, regulatory changes, and market access strategies.
- Affiliation: Syenza News is brought to the public by Syenza, a consultancy specializing in market access, pharmaceutical policy, and health economics, founded by João L. Carapinha, Ph.D.
- Online Presence: We are active on platforms such as LinkedIn and X (Twitter), where we share updates and engage with the healthcare community.
Contributors
AI Use Policy & Disclosure
At Syenza News, we believe in embracing the future of technology to elevate the quality and reach of healthcare communication. In line with the progressive disclosure guidelines of leading international medical and scientific journals (such as JAMA, The Lancet, and the International Committee of Medical Journal Editors), we actively and responsibly integrate Generative AI technologies into our editorial workflow.
We utilize AI tools to assist our editorial team in brainstorming, grammar editing, structural refining, data visualization, and enhancing the overall clarity of our articles. However, technology never replaces human expertise. Every piece of analysis and reporting undergoes rigorous expert review and validation by our contributors. Final editorial control and authorship remain entirely human, and we maintain complete, ultimate accountability for all published content. By combining advanced AI-assisted refinement with deep clinical and economic expertise, we ensure that Syenza News delivers the most accurate, engaging, and impactful value science perspectives to our global audience.